Literature DB >> 20551097

Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database.

Jerome Avouac1, Ulrich Walker, Alan Tyndall, André Kahan, Marco Matucci-Cerinic, Yannick Allanore, I Miniati, A Muller, F Iannone, O Distler, R Becvar, S Sierakowsky, O Kowal-Bielecka, P Coelho, J Cabane, M Cutolo, Y Shoenfeld, G Valentini, J Rovensky, G Riemekasten, P Vlachoyiannopoulos, R Caporali, S Jiri, M Inanc, I Zimmermann Gorska, P Carreira, S Novak, L Czirjak, F Oliveira Ramos, M Jendro, C Chizzolini, E J Kucharz, J Richter, F Cozzi, B Rozman, C M Mallia, A Gabrielli, D Farge, H P Kiener, D Schöffel, P Airo, F Wollheim, D Martinovic, F Trotta, S Jablonska, K Reich, S Bombardieri, P Siakka, R Pellerito, L M Bambara, J Morovic-Vergles, C Denton, R Hinrichs, F Van den Hoogen, N Damjanov, I Kötter, V Ortiz, S Heitmann, D Krasowska, M Seidel, P Hasler, J M Van Laar, J P Kaltwasser, I Foeldvari, A Juan Mas, G Bajocchi, M Wislowska, J A Pereira Da Silva, S Jacobsen, M Worm, W Graniger, A Kuhn, A Stankovic, R Cossutta, M Majdan, L Damjanovska Rajcevska, M Tikly, E L Nasonov, K Steinbrink, A Herrick, U Müller-Ladner, A Dinc, R Scorza, K Sondergaard, F Indiveri, H Nielsen, Z Szekanecz, R M Silver, M Antivalle, I B Espinosa, P García de la Pena Lefebvre, O Midtvedt, D Launay, F Valesini, P Tuvik, R M Ionescu, N Del Papa, S Pinto, F Wigley, C Mihai, M Sinziana Capranu, C Sunderkötter, J B Jun, S Alhasani, J H Distler, E Ton, T Soukup, J Seibold, S Zeni, P Nash, L Mouthon, F De Keyser, M T Duruöz, F P Cantatore, G Strauss, C A von Mülhen, M R Pozzi, K Eyerich, J Szechinski, M Keiserman, F A Houssiau, J A Román-Ivorra, B Krummel-Lorenz, M Aringer, R Westhovens, F Bellisai, M Mayer, F Stoeckl, M Uprus, A Volpe, M Buslau, S Yavuz, B Granel, A Valderílio Feijó, F Del Galdo, S Popa, T Zenone, X Ricardo Machado, M Pileckyte, S Stebbings, A Mathieu, A Tulli, T Tourinho, R Souza, R Acayaba de Toledo, L Stamp, K Solanki, D Veale, J Francisco Marques Neto, G F Bagnato, E Loyo, S Toloza, M Li, W Ahmed Abdel Atty Mohamed, V Cobankara, J Olas, F Salsano, F Oksel, C M Tanaseanu, R Foti, C Ancuta, M Vonk, P Caramashi, L Beretta, A Balbir, A Chiàla, K Pasalic Simic, M Ghio, B Stamenkovic, S Rednic, N Host, R Pellerito, E Hachulla, D E Furst.   

Abstract

OBJECTIVE: To determine the prevalence of and independent factors associated with joint involvement in a large population of patients with systemic sclerosis (SSc).
METHODS: This study was cross-sectional, based on data collected on patients included in the European League Against Rheumatism (EULAR) Scleroderma Trials and Research (EUSTAR) registry. We queried this database to extract data regarding global evaluation of patients with SSc and the presence of any clinical articular involvement: synovitis (tender and swollen joints), tendon friction rubs (rubbing sensation detected as the tendon was moved), and joint contracture (stiffness of the joints that decreased their range of motion). Overall joint involvement was defined by the occurrence of synovitis and/or joint contracture and/or tendon friction rubs.
RESULTS: We recruited 7286 patients with SSc; their mean age was 56 +/- 14 years, disease duration 10 +/- 9 years, and 4210 (58%) had a limited cutaneous disease subset. Frequencies of synovitis, tendon friction rubs, and joint contractures were 16%, 11%, and 31%, respectively. Synovitis, tendon friction rubs, and joint contracture were more prevalent in patients with the diffuse cutaneous subset and were associated together and with severe vascular, muscular, renal, and interstitial lung involvement. Moreover, synovitis had the highest strength of association with elevated acute-phase reactants taken as the dependent variable.
CONCLUSION: Our results highlight the striking level of articular involvement in SSc, as evaluated by systematic examination in a large cohort of patients with SSc. Our data also show that synovitis, joint contracture, and tendon friction rubs are associated with a more severe disease and with systemic inflammation.

Entities:  

Mesh:

Year:  2010        PMID: 20551097     DOI: 10.3899/jrheum.091165

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  43 in total

1.  Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment.

Authors:  Amber Young; Rajaie Namas; Carole Dodge; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-07-19

2.  Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis.

Authors:  Vivek Nagaraja; Marco Matucci-Cerinic; Daniel E Furst; Masataka Kuwana; Yannick Allanore; Christopher P Denton; Ganesh Raghu; Vallerie Mclaughlin; Panduranga S Rao; James R Seibold; John D Pauling; Michael L Whitfield; Dinesh Khanna
Journal:  Arthritis Rheumatol       Date:  2020-05-18       Impact factor: 10.995

Review 3.  Ultrasound in systemic sclerosis. A multi-target approach from joint to lung.

Authors:  Marwin Gutierrez; Carlos Pineda; Tomas Cazenave; Marco Piras; Gian Luca Erre; Antonella Draghessi; Rossella De Angelis; Walter Grassi
Journal:  Clin Rheumatol       Date:  2014-02-18       Impact factor: 2.980

4.  Sonographically guided hydrodissection and corticosteroid injection for scleroderma hand.

Authors:  Suzanne L DeLea; Natalia R Chavez-Chiang; Janet L Poole; Hillary E Norton; Wilmer L Sibbitt; Arthur D Bankhurst
Journal:  Clin Rheumatol       Date:  2011-01-15       Impact factor: 2.980

5.  Musculoskeletal Involvement in SSc Is Associated with Worse Scores on Short Form-36 and Scleroderma Health Assessment Questionnaire and Lower Tumor Necrosis Factor-α Gene Expression in Peripheral Blood Mononuclear Cells.

Authors:  Eliza R Pelrine; Marie-Dominique Ah-Kioon; Meng Zhang; Franck J Barrat; Robert F Spiera; Jessica K Gordon
Journal:  HSS J       Date:  2016-07-22

6.  Acroosteolysis in systemic sclerosis: An insight into hypoxia-related pathogenesis.

Authors:  Simon Siao-Pin; Laura-Otilia Damian; Laura Mirela Muntean; Simona Rednic
Journal:  Exp Ther Med       Date:  2016-10-05       Impact factor: 2.447

7.  Reliability and Validity of the Tender and Swollen Joint Counts and the Modified Rodnan Skin Score in Early Diffuse Cutaneous Systemic Sclerosis: Analysis from the Prospective Registry of Early Systemic Sclerosis Cohort.

Authors:  Jessica K Gordon; Gandikota Girish; Veronica J Berrocal; Meng Zhang; Christopher Hatzis; Shervin Assassi; Elana J Bernstein; Robyn T Domsic; Faye N Hant; Monique Hinchcliff; Elena Schiopu; Virginia D Steen; Tracy M Frech; Dinesh Khanna
Journal:  J Rheumatol       Date:  2017-03-15       Impact factor: 4.666

8.  Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis.

Authors:  Rositsa Karalilova; Maria Kazakova; Tanya Sapundzhieva; Valentin Dichev; Zguro Batalov; Victoria Sarafian; Anastas Batalov
Journal:  Rheumatol Int       Date:  2019-08-02       Impact factor: 2.631

9.  Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms.

Authors:  Stefan Schanz; Jörg Henes; Anja Ulmer; Ina Kötter; Gerhard Fierlbeck; C D Claussen; Marius Horger
Journal:  Eur Radiol       Date:  2012-07-29       Impact factor: 5.315

Review 10.  The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.

Authors:  Lesley Ann Saketkoo; Jeanette H Magnus; Mittie K Doyle
Journal:  Am J Med Sci       Date:  2014-01       Impact factor: 2.378

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.